Back to Search Start Over

Malignant ectomesenchymoma in children: The European pediatric Soft tissue sarcoma Study Group experience.

Authors :
Milano GM
Orbach D
Casanova M
Berlanga P
Schoot RA
Corradini N
Brennan B
Ramirez-Villar GL
Lyngsie Hjalgrim L
van Noesel MM
Alaggio R
Ferrari A
Source :
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Feb; Vol. 70 (2), pp. e30116. Date of Electronic Publication: 2022 Nov 28.
Publication Year :
2023

Abstract

Malignant ectomesenchymoma (MEM) is an extremely rare soft tissue tumor typical of young children, currently included in the category of skeletal muscle malignancies and characterized by a neuroblastic component. This study describes a series of 10 patients prospectively registered in the European paediatric Soft tissue sarcoma Study Group (EpSSG) database Of the 10 cases, seven had an initial local diagnosis of rhabdomyosarcoma. All patients received chemotherapy according to rhabdomyosarcoma strategy, four had radiotherapy. Overall, six patients were alive in first remission, two in second remission and one after second tumor. Only the patient with initially metastatic tumor died of disease.<br /> (© 2022 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1545-5017
Volume :
70
Issue :
2
Database :
MEDLINE
Journal :
Pediatric blood & cancer
Publication Type :
Academic Journal
Accession number :
36440693
Full Text :
https://doi.org/10.1002/pbc.30116